140 related articles for article (PubMed ID: 1847999)
1. Molecular analysis of the p53 alleles in primary hepatocellular carcinomas and cell lines.
Hosono S; Lee CS; Chou MJ; Yang CS; Shih CH
Oncogene; 1991 Feb; 6(2):237-43. PubMed ID: 1847999
[TBL] [Abstract][Full Text] [Related]
2. Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas.
Hosono S; Chou MJ; Lee CS; Shih C
Oncogene; 1993 Feb; 8(2):491-6. PubMed ID: 8093978
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a transforming N-ras gene in the human hepatoma cell line Hep G2: additional evidence for the importance of c-myc and ras cooperation in hepatocarcinogenesis.
Richards CA; Short SA; Thorgeirsson SS; Huber BE
Cancer Res; 1990 Mar; 50(5):1521-7. PubMed ID: 2154325
[TBL] [Abstract][Full Text] [Related]
4. Genetic alterations at the splice junction of p53 gene in human hepatocellular carcinoma.
Hsu HC; Huang AM; Lai PL; Chien WM; Peng SY; Lin SW
Hepatology; 1994 Jan; 19(1):122-8. PubMed ID: 7903951
[TBL] [Abstract][Full Text] [Related]
5. Status of the p53 tumor suppressor gene in human squamous carcinoma cell lines.
Reiss M; Brash DE; Muñoz-Antonia T; Simon JA; Ziegler A; Vellucci VF; Zhou ZL
Oncol Res; 1992; 4(8-9):349-57. PubMed ID: 1486218
[TBL] [Abstract][Full Text] [Related]
6. [p53 gene expression of human hepatoma cell lines and their sensitivities to parvovirus H-1].
Guo LP; Li GD; Xu H; Huang QS; Lin WM; Ling WH; Huang H; Luo ZY; Su ZZ
Shi Yan Sheng Wu Xue Bao; 1999 Mar; 32(1):23-9. PubMed ID: 12548791
[TBL] [Abstract][Full Text] [Related]
7. Expression of p53 gene in 184 unifocal hepatocellular carcinomas: association with tumor growth and invasiveness.
Hsu HC; Tseng HJ; Lai PL; Lee PH; Peng SY
Cancer Res; 1993 Oct; 53(19):4691-4. PubMed ID: 8402647
[TBL] [Abstract][Full Text] [Related]
8. [The relation between p53 mutations and tumor invasiveness of human hepatocellular carcinoma].
Qin L; Tang Z; Liu K
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):405-8. PubMed ID: 8697987
[TBL] [Abstract][Full Text] [Related]
9. p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation.
Volkmann M; Hofmann WJ; Müller M; Räth U; Otto G; Zentgraf H; Galle PR
Oncogene; 1994 Jan; 9(1):195-204. PubMed ID: 8302580
[TBL] [Abstract][Full Text] [Related]
10. Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes.
Ruggeri B; Zhang SY; Caamano J; DiRado M; Flynn SD; Klein-Szanto AJ
Oncogene; 1992 Aug; 7(8):1503-11. PubMed ID: 1630814
[TBL] [Abstract][Full Text] [Related]
11. Alterations of the p53 tumor suppressor gene during mouse skin tumor progression.
Ruggeri B; Caamano J; Goodrow T; DiRado M; Bianchi A; Trono D; Conti CJ; Klein-Szanto AJ
Cancer Res; 1991 Dec; 51(24):6615-21. PubMed ID: 1742735
[TBL] [Abstract][Full Text] [Related]
12. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.
Murakami Y; Hayashi K; Hirohashi S; Sekiya T
Cancer Res; 1991 Oct; 51(20):5520-5. PubMed ID: 1655254
[TBL] [Abstract][Full Text] [Related]
13. Detection of aberrations of the p53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis.
Murakami Y; Hayashi K; Sekiya T
Cancer Res; 1991 Jul; 51(13):3356-61. PubMed ID: 2054775
[TBL] [Abstract][Full Text] [Related]
14. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
15. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
[TBL] [Abstract][Full Text] [Related]
16. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
17. Target gene modulation in hepatocellular carcinomas by decreased DNA-binding of p53 mutations.
Kubicka S; Trautwein C; Niehof M; Manns M
Hepatology; 1997 Apr; 25(4):867-73. PubMed ID: 9096590
[TBL] [Abstract][Full Text] [Related]
18. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
[TBL] [Abstract][Full Text] [Related]
19. TP53 and hepatocellular carcinoma.
Puisieux A; Ozturk M
Pathol Biol (Paris); 1997 Dec; 45(10):864-70. PubMed ID: 9769950
[TBL] [Abstract][Full Text] [Related]
20. Splicing mutations of the p53 gene in human hepatocellular carcinoma.
Lai MY; Chang HC; Li HP; Ku CK; Chen PJ; Sheu JC; Huang GT; Lee PH; Chen DS
Cancer Res; 1993 Apr; 53(7):1653-6. PubMed ID: 8384081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]